INTRATUMORAL T-CELL AND B-CELL RECEPTOR ARCHITECTURE ASSOCIATES WITH DISTINCT IMMUNE TUMOR MICROENVIRONMENT FEATURES AND CLINICAL OUTCOMES OF ANTI-PD-1/L1 IMMUNOTHERAPY
Account has been disabled due to a violation of Terms of Service. Contact Moderators
Account has been disabled due to a violation of Terms of Service. Contact Moderators